Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

75
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
75
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

351
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
351
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

228
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
228

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychiatric and neurological predictors of early ADHD medication discontinuation across the lifespan: a multinational study.

BMJ mental health·2026
Same author

Estimating the Sodium Content: A Case Series of Benign and Malignant Renal Tumours Using <sup>23</sup>Na-MRI at 3 T.

NMR in biomedicine·2026
Same author

Breastfeeding and Development of Attention-Deficit/Hyperactivity Disorder Symptoms Across Childhood.

Biological psychiatry·2026
Same author

Efficacy and target engagement of dopamine agonist pramipexole for anhedonic depression: a randomized placebo-controlled trial.

Nature medicine·2026
Same author

Phase 1 dose-escalation trial combining sulfasalazine and stereotactic radiosurgery in patients with recurrent glioblastoma.

Redox biology·2026
Same author

Blocking β-alanine synthesis triggers widespread perturbations of energy and lipid metabolism in the brain.

Molecular metabolism·2026
Same journal

Diversity of words and words for diversity.

Frontiers in psychiatry·2026
Same journal

Integration of transcriptome profiling to identify key genes involved in the interplay between oxidative stress and mitophagy in major depressive disorder, followed by multidimensional phenotypic validation.

Frontiers in psychiatry·2026
Same journal

Diagnosis of prolonged grief disorder among older adults: mapping physicians' knowledge and practice, and evaluating the effectiveness of a brief targeted training program.

Frontiers in psychiatry·2026
Same journal

A gender-emotion interaction multi-task network for depression recognition via transformer-based multimodal fusion.

Frontiers in psychiatry·2026
Same journal

Data-driven mechanistic analysis of digital therapeutic-assisted training and evaluation of personalized protocol effects in children with attention deficit/hyperactivity disorder.

Frontiers in psychiatry·2026
Same journal

Persistent neuropsychiatric dysfunction following chronic tiletamine-containing e-cigarette use: a case report.

Frontiers in psychiatry·2026
See all related articles

Related Experiment Video

Updated: Jul 25, 2025

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.1K

Electroconvulsive therapy triggers a reversible decrease in brain N-acetylaspartate.

Vera J Erchinger1,2, Alexander R Craven3,4,5, Lars Ersland5

  • 1Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Frontiers in Psychiatry
|June 26, 2023
PubMed
Summary
This summary is machine-generated.

Electroconvulsive therapy (ECT) may work by disrupting and rewiring brain networks. This study found decreased N-acetylaspartate (NAA) levels after ECT, supporting the proposed mechanism for treating depression.

Keywords:
1H-MRS nuclear magnetic resonance spectroscopycholinedepressionelectroconvulsive therapyglutamatemyoinositolneurometabolites

More Related Videos

Direct-current Stimulation and Multi-electrode Array Recording of Seizure-like Activity in Mice Brain Slice Preparation
09:39

Direct-current Stimulation and Multi-electrode Array Recording of Seizure-like Activity in Mice Brain Slice Preparation

Published on: June 7, 2016

10.6K
Induction of an Isoelectric Brain State to Investigate the Impact of Endogenous Synaptic Activity on Neuronal Excitability In Vivo
10:19

Induction of an Isoelectric Brain State to Investigate the Impact of Endogenous Synaptic Activity on Neuronal Excitability In Vivo

Published on: March 31, 2016

8.2K

Related Experiment Videos

Last Updated: Jul 25, 2025

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.1K
Direct-current Stimulation and Multi-electrode Array Recording of Seizure-like Activity in Mice Brain Slice Preparation
09:39

Direct-current Stimulation and Multi-electrode Array Recording of Seizure-like Activity in Mice Brain Slice Preparation

Published on: June 7, 2016

10.6K
Induction of an Isoelectric Brain State to Investigate the Impact of Endogenous Synaptic Activity on Neuronal Excitability In Vivo
10:19

Induction of an Isoelectric Brain State to Investigate the Impact of Endogenous Synaptic Activity on Neuronal Excitability In Vivo

Published on: March 31, 2016

8.2K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Biochemistry

Background:

  • Electroconvulsive therapy (ECT) is a treatment for severe depression.
  • A proposed model suggests ECT therapeutically works through sequential disruption, potentiation, and rewiring of brain networks.
  • Biochemical alterations, including changes in N-acetylaspartate (NAA), choline, myo-inositol (mI), and glutamate/glutamine (Glx), are hypothesized to underlie these network changes.

Purpose of the Study:

  • To investigate biochemical alterations in the brain during electroconvulsive therapy (ECT).
  • To test the "disrupt, potentiate, and rewire" hypothesis of ECT's therapeutic mechanism.
  • To validate findings across different magnetic resonance spectroscopy (MRS) quantification methods.

Main Methods:

  • Utilized magnetic resonance spectroscopy (MRS) to measure brain metabolites in 31 patients with depression and 19 healthy controls.
  • Collected data before, during, and after a series of ECT sessions.
  • Quantified metabolites using both creatine ratios and water-referenced values to ensure result validity.

Main Results:

  • N-acetylaspartate (NAA) levels in the anterior cingulate cortex significantly decreased after ECT treatment.
  • NAA levels returned to baseline 6 months post-ECT and subsequently increased, supporting the proposed model.
  • Changes in other metabolites (choline, mI, Glx) were inconsistent and could not be validated across quantification methods.

Conclusions:

  • The observed robust changes in NAA levels across quantification methods support key aspects of the "disrupt, potentiate, and rewire" model of ECT.
  • Findings highlight the importance of consistent metabolite quantification methods in MRS research for ECT.
  • This study provides biochemical evidence contributing to the understanding of ECT's therapeutic effects in depression.